(Q44517936)

3 December 2017

Oral high-dose progestins as treatment for advanced breast cancer (English)

1 reference

3 December 2017

2

Kvinnsland S

1 reference

3 December 2017

1

Lundgren S

1 reference

3 December 2017

Utaaker E

3

1 reference

3 December 2017

1 January 1989

1 reference

3 December 2017

1 reference

3 December 2017

28

1 reference

3 December 2017

811-816

1 reference

3 December 2017

6

1 reference

Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment

3 December 2017

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092313

The role of progestins and progesterone receptors in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092313

Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092313

Induction of Human Endometrial Estradiol Dehydrogenase by Progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092313

Effects of progestins on estradiol receptor levels in human endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092313

Assessment of response to therapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092313

Survival patterns in hormone treated advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092313

Lack of correlations between plasma concentration of medroxyprogesterone acetate, hypothalamic-pituitary function, and tumour response in patients with advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841868909092313

10.3109/02841868909092313

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference

PubMed ID

2532917